BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 14974118)

  • 1. The prenatal diagnosis of congenital disorders of glycosylation (CDG).
    Matthijs G; Schollen E; Van Schaftingen E
    Prenat Diagn; 2004 Feb; 24(2):114-6. PubMed ID: 14974118
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular diagnosis of congenital disorders of glycosylation].
    Vuillaumier-Barrot S
    Ann Biol Clin (Paris); 2005; 63(2):135-43. PubMed ID: 15771971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased biosynthesis of glycosphingolipids in congenital disorder of glycosylation Ia (CDG-Ia) fibroblasts.
    Sala G; Dupré T; Seta N; Codogno P; Ghidoni R
    Pediatr Res; 2002 Nov; 52(5):645-51. PubMed ID: 12409508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diagnosis of congenital disorder of glycosylation type Ia (CDG-Ia) by cordocentesis and transferrin isoelectric focussing of serum of a 27-week fetus with non-immune hydrops.
    Edwards M; McKenzie F; O'callaghan S; Somerset D; Woodford P; Spilsbury J; Fietz M; Fletcher J
    Prenat Diagn; 2006 Oct; 26(10):985-8. PubMed ID: 16915591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital disorders of glycosylation type Ia and Ib. Genetic, biochemical and clinical studies.
    Kjaergaard S
    Dan Med Bull; 2004 Nov; 51(4):350-63. PubMed ID: 16009061
    [No Abstract]   [Full Text] [Related]  

  • 6. Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation.
    Cylwik B; Naklicki M; Chrostek L; Gruszewska E
    Acta Biochim Pol; 2013; 60(2):151-61. PubMed ID: 23730680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disturbances in aminoglycan synthesis].
    Jaeken J
    Arch Pediatr; 1999; 6 Suppl 2():203s-205s. PubMed ID: 10370481
    [No Abstract]   [Full Text] [Related]  

  • 8. [Congenital disorders of glycosylation].
    Durand G; Dupré T; Vuillaumier-Barrot S; Seta N
    Ann Pharm Fr; 2003; 61(5):330-9. PubMed ID: 13130291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency.
    de Koning TJ; Dorland L; van Diggelen OP; Boonman AM; de Jong GJ; van Noort WL; De Schryver J; Duran M; van den Berg IE; Gerwig GJ; Berger R; Poll-The BT
    Biochem Biophys Res Commun; 1998 Apr; 245(1):38-42. PubMed ID: 9535779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.
    Schollen E; Kjaergaard S; Martinsson T; Vuillaumier-Barrot S; Dunoe M; Keldermans L; Seta N; Matthijs G
    J Med Genet; 2004 Nov; 41(11):877-80. PubMed ID: 15520415
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevation of plasma aspartylglucosaminidase is a useful marker for the congenital disorders of glycosylation type I (CDG I).
    Jackson M; Clayton P; Grunewald S; Keir G; Mills K; Mills P; Winchester B; Worthington V; Young E
    J Inherit Metab Dis; 2005; 28(6):1197-8. PubMed ID: 16435229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib).
    Schollen E; Dorland L; de Koning TJ; Van Diggelen OP; Huijmans JG; Marquardt T; Babovic-Vuksanovic D; Patterson M; Imtiaz F; Winchester B; Adamowicz M; Pronicka E; Freeze H; Matthijs G
    Hum Mutat; 2000 Sep; 16(3):247-52. PubMed ID: 10980531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG).
    Schollen E; Martens K; Geuzens E; Matthijs G
    Eur J Hum Genet; 2002 Oct; 10(10):643-8. PubMed ID: 12357336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital disorder of glycosylation Ic due to a de novo deletion and an hALG-6 mutation.
    Eklund EA; Sun L; Yang SP; Pasion RM; Thorland EC; Freeze HH
    Biochem Biophys Res Commun; 2006 Jan; 339(3):755-60. PubMed ID: 16321363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
    Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
    Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital disorders of glycosylation syndromes.
    Pascual-Castroviejo I
    Dev Med Child Neurol; 2002 May; 44(5):357-8. PubMed ID: 12033725
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency).
    Schollen E; Frank CG; Keldermans L; Reyntjens R; Grubenmann CE; Clayton PT; Winchester BG; Smeitink J; Wevers RA; Aebi M; Hennet T; Matthijs G
    J Med Genet; 2004 Jul; 41(7):550-6. PubMed ID: 15235028
    [No Abstract]   [Full Text] [Related]  

  • 18. Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!
    Jaeken J
    J Inherit Metab Dis; 2003; 26(2-3):99-118. PubMed ID: 12889654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased brain lactate during stroke-like episode in a patient with congenital disorder of glycosylation type Ia.
    van Baalen A; Stephani U; Rohr A
    Brain Dev; 2009 Feb; 31(2):183. PubMed ID: 18835116
    [No Abstract]   [Full Text] [Related]  

  • 20. Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype).
    Barone R; Sturiale L; Fiumara A; Uziel G; Garozzo D; Jaeken J
    J Inherit Metab Dis; 2007 Feb; 30(1):107. PubMed ID: 17186415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.